Filtered By:
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of relevance. This is page number 11.

Order by Relevance | Date

Total 852 results found since Jan 2013.

Black, Hispanic, Poor Young Women Less Likely to Complete HPV Vaccinations
08/30/2011, American Journal of Preventive Medicine, Barriers that hinder young African-American, Hispanic and poor women from completing a series of three vaccinations to prevent human papillomavirus infection (HPV) also leave them at higher risk for cervical cancer and death.
Source: Health Behavior News Service - February 6, 2013 Category: Consumer Health News Source Type: news

Africa: Alliance Gives At-Risk Girls Vaccine Against Cancer-Causing Virus
[State Department]An international alliance to broaden the availability of immunizations announced a plan February 4 to distribute vaccine to protect girls from human papillomavirus (HPV) in eight developing world nations.
Source: AllAfrica News: Health and Medicine - February 6, 2013 Category: African Health Source Type: news

More parents say they won't vaccinate daughters against HPV, researchers find
(Mayo Clinic) A rising percentage of parents say they won't have their teen daughters vaccinated to protect against the human papilloma virus, even though physicians are increasingly recommending adolescent vaccinations, a study by Mayo Clinic and others shows.
Source: EurekAlert! - Medicine and Health - March 18, 2013 Category: Global & Universal Source Type: news

Well: A Push for HPV Vaccinations
Health professionals hope to make the shots more accessible, and to make the vaccine sound less scary to parents and daughters.
Source: NYT Health - March 25, 2013 Category: Consumer Health News Authors: By SABRINA TAVERNISE Tags: Family Human Papilloma Virus (HPV) Healthy Consumer Cervical Cancer Sexually Transmitted Diseases Preventive Medicine Body Featured Vaccination and Immunization Source Type: news

Moffitt researchers analyze HPV vaccination disparities among girls from low-income families
(H. Lee Moffitt Cancer Center & Research Institute) Researchers at Moffitt Cancer Center and colleagues at the University of Florida studied health care providers to determine the factors associated with disparities in Human Papillomavirus vaccination among girls, ages nine to 17, from low-income families. They found that physician vaccination strategies and the type of practice play a role in whether or not girls were vaccinated.
Source: EurekAlert! - Medicine and Health - March 27, 2013 Category: Global & Universal Source Type: news

Current HPV vaccine may not help some women with immune problems
(Fox Chase Cancer Center) Women with HIV acquire cancer-causing forms of the human papillomavirus that are not included in the current HPV vaccines Gardasil and Cervarix, according to new research from Fox Chase Cancer Center being presented at the AACR Annual Meeting 2013 on Sunday, April 7.
Source: EurekAlert! - Medicine and Health - April 7, 2013 Category: Global & Universal Source Type: news

Research Letter, Viewpoint, Invited Commentary Examine Cervical Cancer Screening Intervals
JAMA Internal Medicine Study Highlights A research letter by Zahava Berkowitz, M.S.P.H., M.Sc., of the Centers for Disease Control and Prevention, and colleagues found that most of the 2,087 primary care clinicians surveyed recommended Papanicolaou (pap) tests sooner than recommended by guidelines after co-testing for the human papillomavirus (HPV)...
Source: Health News from Medical News Today - April 8, 2013 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

Reasons for Not Vaccinating Adolescents: National Immunization Survey of Teens, 2008-2010
CONCLUSIONS: Despite doctors increasingly recommending adolescent vaccines, parents increasingly intend not to vaccinate female teens with HPV. The concern about safety of HPV grew with each year. Addressing specific and growing parental concerns about HPV will require different considerations than those for the other vaccines.
Source: PEDIATRICS - April 1, 2013 Category: Pediatrics Authors: Darden, P. M., Thompson, D. M., Roberts, J. R., Hale, J. J., Pope, C., Naifeh, M., Jacobson, R. M. Tags: Adolescent Medicine Article Source Type: research

An exploration of human papillomavirus‐related cervical cancer prevention experiences among college women: a descriptive qualitative approach
ConclusionCollege women experience difficulties with human papillomavirus‐related cervical cancer prevention. They desire to have a publicly funded human papillomavirus immunisation programme, friendly medical environments, sufficient knowledge and open‐minded society to maintain their health. Such reflection information is helpful to design effective human papillomavirus‐related cervical cancer prevention campaigns. Relevance to clinical practiceYoung women do not know how to protect against human papillomavirus infection, although human papillomavirus‐related cervical cancer prevention methods are definite. This ...
Source: Journal of Clinical Nursing - March 25, 2013 Category: Nursing Authors: Yu‐Ching Tu, Hsiu‐Hung Wang Tags: Original Article Source Type: research

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
Conclusions: The HPV16-SLP vaccine was well tolerated and induced a broad IFNγ-associated T-cell response in patients with advanced or recurrent HPV16-induced gynecological carcinoma but neither induced tumor regression nor prevented progressive disease. We, therefore, plan to use this vaccine in combination with chemotherapy and immunomodulation.
Source: Journal of Translational Medicine - April 4, 2013 Category: Research Authors: Mariette I E van PoelgeestMarij J P WeltersEdith M G van EschLinda F M StynenboschGijs KerpershoekEls van Persijn van MeertenMuriel van den HendeMargriet J G LöwikDorien M A Berends-van der MeerLorraine FathersA Rob P M ValentijnJaap OostendorpGert Jan F Source Type: research

Human Papillomavirus Vaccine Initiation and Awareness: U.S. Young Men in the 2010 National Health Interview Survey
Conclusions: HPV vaccination initiation among men aged 18–26 years in 2010 was low. HPV and HPV vaccine awareness were also low, and messages in this area directed to men are needed. Since ACIP published a recommendation for routine use of HPV4 among men/boys in December 2011, continued monitoring of HPV vaccination uptake among men aged 18–26 years is useful for evaluating the vaccination campaigns, and planning and implementing strategies to increase coverage.
Source: American Journal of Preventive Medicine - April 1, 2013 Category: Global & Universal Authors: Peng-jun Lu, Walter W. Williams, Jun Li, Christina Dorell, David Yankey, Deanna Kepka, Eileen F. Dunne Tags: Research Articles Source Type: research

Study compares effectiveness of 2 vs. 3 doses of HPV vaccine for girls and young women
(The JAMA Network Journals) With the number of doses and cost of human papillomavirus (HPV) vaccines a barrier to global implementation, researchers have found that girls who received two doses of HPV vaccine had immune responses to HPV-16 and HPV-18 infection that were noninferior to (not worse than) the responses for young women who received three doses, according to a study in the May 1 issue of JAMA, a theme issue on child health.
Source: EurekAlert! - Medicine and Health - April 30, 2013 Category: Global & Universal Source Type: news

Girls May Need Fewer Gardasil Shots, Study Suggests
Preteens appear to get same protection with two doses of HPV vaccine as young women who get three
Source: Fertility News - Doctors Lounge - April 30, 2013 Category: Reproduction Medicine Authors: webmaster at doctorslounge.com Tags: Infections, Pediatrics, Pharmacy, Reproductive Medicine, News, Source Type: news

Updated Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Released
The National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA) announce the release of the updated Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents.   Selected key updates to the guidelines include the following: New information on the diagnosis and management of immune reconstitution inflammatory syndrome (IRIS), particularly as it relates to tuberculosis and cryptococcosis. New guidance for managing IRIS related to each opport...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - May 7, 2013 Category: Infectious Diseases Source Type: news

GARDASIL® Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant, Merck’s HPV Vaccine, Available to Developing Countries through UNICEF Tender
Dateline City:  WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the company has been awarded a significant portion of the UNICEF human papillomavirus (HPV) vaccine tender, and will provide sustained supply of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] to GAVI-eligible countries. This agreement follows the GAVI Alliance’s earlier announcement that HPV vaccines would be included in its portfolio for th...
Source: Merck.com - Corporate News - May 9, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Prescription Medicine News Vaccine News Corporate News Latest News Source Type: news